Skip to content


Bromday, Bromsite, Prolensa, Xibrom, Yellox (bromfenac) is a small molecule pharmaceutical. Bromfenac was first approved as Bromday on 2005-03-24. It is used to treat eye pain, inflammation, and postoperative pain in the USA. It has been approved in Europe to treat ophthalmologic surgical procedures and postoperative pain. The pharmaceutical is active against prostaglandin G/H synthase 1. In addition, it is known to target DNA polymerase III subunit beta. Prolensa's patents are valid until 2033-11-11 (FDA).
Trade Name Yellox
Common Name Bromfenac
Indication eye pain, inflammation, ophthalmologic surgical procedures, postoperative pain
Drug Class Anti-inflammatory agents (acetic acid derivatives)
Get full access now